Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
Principal MidCap Growth III R1 PHASX
- NAV / 1-Day Return 7.23 / +0.56 %
- Total Assets 796.4 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.680%
- Distribution Fee Level High
- Share Class Type Retirement, Medium
- Category Mid-Cap Growth
- Investment Style Mid Growth
- Min. Initial Investment —
- Status Limited
- TTM Yield —
- Turnover 49%
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:17 PM GMT+0
Morningstar’s Analysis PHASX
Will PHASX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 17.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
DexCom Inc | 2.39 | 27.0 Mil | Healthcare |
Monolithic Power Systems Inc | 2.11 | 23.8 Mil | Technology |
Tyler Technologies Inc | 1.93 | 21.8 Mil | Technology |
IDEXX Laboratories Inc | 1.92 | 21.7 Mil | Healthcare |
Principal Government Money Market R-6 | 1.76 | 19.8 Mil | — |
PTC Inc | 1.65 | 18.6 Mil | Technology |
MSCI Inc | 1.51 | 17.0 Mil | Financial Services |
Veeva Systems Inc Class A | 1.43 | 16.1 Mil | Healthcare |
Synopsys Inc | 1.29 | 14.6 Mil | Technology |
CoStar Group Inc | 1.29 | 14.5 Mil | Real Estate |